On Apr. 27, 2020, Yield10 Bioscience announced it has obtained a positive response from USDA-APHISﾒs Biotechnology Regulatory Services for its CRISPR genome-edited C3007 trait in Camelina sativa plant lines designed to increase oil content. This clarification of regulatory status under USDA-APHIS guidelines accelerates the path for Yield10 to conduct field trials of the CRISPR genome-edited C3007 plants in the U.S. in the 2020 growing season.